AnnouncedFiled 21 February 2025
Areteia Therapeutics, Inc. has sold $360M so far
Areteia Therapeutics, Inc., a biotech company based in Chapel Hill, NC, has sold $360M so far in its equity round, according to a filing dated 21 February 2025.
Announced on 13 February 2024, 374 days before the filing. businesswire.com ↗
- Filed
- 21 February 2025
- First filed
- 14 July 2022
- Round
- Equity round (amended filing)
- Amount sold
- $360M
- Offering size
- $445M
- Investors so far
- 16
- Based in
- Chapel Hill, NC
- Website
- areteiatx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 99% of the 1,405 tracked raises with an amount filed in 2025, and than 100% of the 112 in biotech.
Areteia Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 21 Feb 2025 | Amended filing | $360M | This raise |
| 22 Feb 2024 | Amended filing | $275M | This raise |
| 14 Jul 2022 | New filing | $175M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.